Eazy Testing Inc. Becomes AditxtScore™ Channel Partner, to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring with its Walk-In, Concierge, and Pre-Flight Services
04. März 2021 08:30 ET
|
Aditx Therapeutics, Inc.
Mountain View, CA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a biotech innovation company focused on improving the...
Immunologist and Clinical Transplant Expert, Dolly B. Tyan, PhD, Joins Aditxt as Senior VP of Clinical Development - Transplantation
29. Januar 2021 09:24 ET
|
Aditx Therapeutics, Inc.
Dr. Tyan Will Lead and Advance Organ Transplantation Therapeutic Program Mountain View, CA, Jan. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire-- Aditx Therapeutics, Inc. (Aditxt) (the “Company”)...
Aditxt Secures $5 Million Financing to Scale AditxtScore™ Operational Capacity
26. Januar 2021 08:54 ET
|
Aditx Therapeutics, Inc.
Balance Sheet Further Strengthened by Receipt of Additional $3.3 Million from Exercise of Existing Warrants Mountain View, CA, Jan. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx...
AditxtScore™ Immune Monitoring Service Will be Operational on February 1st
21. Januar 2021 08:00 ET
|
Aditx Therapeutics, Inc.
Company Plans to Offer Service through Channel Partners Mountain View, CA, Jan. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX),...
Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore™ for COVID-19 Immune Monitoring Service
14. Dezember 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Service Availability is Expected in January 2021 MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Aditx Therapeutics, Inc. (Aditxt) (the “Company”)...
Aditxt to Present at the 13th Annual LD Micro Main Event Conference
08. Dezember 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Presentation on Tuesday December 15th at 11:00am EST LOS ANGELES, CA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life...
Physician and Media Personality Dr. Drew and Aditxt CEO to Reveal and Discuss Their Personal AditxtScore™ for COVID-19 Results During AditxtEngage™ Live Event on Tuesday, December 1st at 10:00 am ET
30. November 2020 08:30 ET
|
Aditx Therapeutics, Inc.
To Indicate Interest in a Personal AditxtScore™ for COVID-19, Visit AditxtScore.com MOUNTAIN VIEW, CA, Nov. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Aditx Therapeutics, Inc. (Aditxt) (the...
Aditxt Appoints Anthony Voorhies as Head of Business Development for AditxtScore™
20. November 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Voorhies has Extensive Business and Industry Experience in Diagnostics & Monitoring Mountain View, CA, Nov. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc....
Aditxt Secures CLIA Certification for AditxtScore™ Laboratory Operations in Richmond, VA, and Plans to Launch AditxtScore™ for COVID-19 as a Lab Developed Test (LDT)
19. November 2020 08:30 ET
|
Aditx Therapeutics, Inc.
Upcoming Vaccines Increase the Need for Ongoing Monitoring of Presence and Durability of Immunity Mountain View, CA , Nov. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics,...
Aditxt Provides Business Update and Files Third Quarter 2020 10-Q
13. November 2020 08:00 ET
|
Aditx Therapeutics, Inc.
Mountain View, CA, Nov. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies...